In the LA area one of the local news channels ran a story on a women who has late stage breast cancer and was really out of options. She and her doctor were just waiting for this drug to be approved. The doc was down to feeling like days mattered. Remember Junius had said in an interview that they drop shipped the drug overnight so a patient that had requested it, since it would have taken a few weeks via normal distribution channels. Well, this was one of those patients. She literally began to feel better in days of treatment. After a few weeks she was able to breath again on her own. So this is the astounding power and efficacy of this drug. An amazing advancement in how oncology treatment has and will change. This is precisely why I invested in this stock years ago. I have way to many eggs in this one basket, but I'm OK with it.
Thanks for the positive and uplifting news. Just think of how many other women were in her position the past 2 years that had no good options thanks to the FDelay. Ironically, considering the 10-12 year time limit on the licensing arrangement with Roche, the delay may actually lead to larger total revenues for IMGN, since they are closer to approval for wider markets.
Best wishes to everyone for a Happy and Blessed Easter!